Effects of flickering light on brain immune cells related to Alzheimer's disease
Diversity Supplement: Effects of stimulation on resilience in brain immune cells
This study is looking at whether flickering light can help brain immune cells work better in mice that have a genetic risk for Alzheimer's, with the hope that it might prevent brain damage and improve health for people with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11090059 on NIH RePORTER |
What this research studies
This research investigates how flickering light at a specific frequency can influence the behavior of brain immune cells, particularly in the context of Alzheimer's disease. The study focuses on microglia, which are crucial for brain health and can become overly reactive in individuals with the ApoE4 genetic risk factor for Alzheimer's. By examining the effects of this flicker stimulation in a mouse model, the research aims to understand if it can help restore normal function to these immune cells and potentially prevent neurodegeneration. The project is led by a graduate student from an under-represented group, emphasizing diversity in scientific research.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a genetic predisposition to Alzheimer's disease, particularly those carrying the ApoE4 allele.
Not a fit: Patients without the ApoE4 genetic risk factor or those who do not have any form of cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new non-invasive interventions that help protect brain health and reduce the risk of Alzheimer's disease.
How similar studies have performed: While the specific approach of using flicker stimulation is novel, related research has shown promise in modulating immune responses in the brain.
Where this research is happening
Atlanta, United States
- Georgia Institute of Technology — Atlanta, United States (Active)
Researchers
- Principal investigator: Singer, Annabelle Catherine — Georgia Institute of Technology
- Study coordinator: Singer, Annabelle Catherine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.